Skip to content

Comparative trial of morphine mouthwash and ketamine mouthwash for oral mucositis

Morphine Mouthwash Versus Ketamine Mouthwash For Acute Pain In Patients Of Hematolymphoid Cancers With Chemotherapy Induced Oral Mucositis - A Randomised Controlled Study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/062050
Enrollment
38
Registered
2024-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue

Interventions

Intervention1: Ketamine: Ketamine Mouthwash [Ketamine mouthwash will be prepared by dissolving 50mg of IV ketamine in 15 ml of 5% dextrose. 18 syringes each containing 15ml of this ketamine mouthwash

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 18 years of age or older Received at least one dose of chemotherapy Having oral mucositis pain score on NRS more than or equal to 6 Able to do mouthwash without swallowing Able to sign the informed consent

Exclusion criteria

Exclusion criteria: Any documented previous hypersensitivity to ketamine Local oral infection Received prior ketamine or morphine doses by any route within 48 h of study initiation. Pregnant or breastfeeding. Patients with hypertension, history of epilepsy and any cardiac conditions. History of any psychiatric disorder that is at the risk of exacerbation.

Design outcomes

Primary

MeasureTime frame
Mean difference in the pain scores between the two arms as reported on the Numerical rating scale(NRS).Timepoint: At Day 3.

Secondary

MeasureTime frame
Mean difference in the pain scores between the two arms at 30 mins and 1 hour as reported on the NRS.Timepoint: At 30 minutes and 1 hour;Numbers and types of adverse effects occurred during the study as reported by the patient using NOSE and also the patient reported adverse effects for ketamine.Timepoint: Day 3;Requirement of opioid analgesics expressed as oral morphine equivalents.Timepoint: Day 3;Time to requirement of first systemic opioid analgesic in hours.Timepoint: Day 3;To assess for the change in the grade of the oral mucositis as assessed by the WHO or CTCAE scale.Timepoint: Day 3;To check the lowest pain score achieved during the course of 3 days using the numerical rating scale.Timepoint: Day 3

Countries

India

Contacts

Public ContactDr. Varun T. M.

Tata Memorial Hospital

jukd2000@yahoo.co.uk02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026